212 related articles for article (PubMed ID: 7484521)
1. Urodynamic effects of Prolase 2 laser prostatectomy in benign prostatic hyperplasia.
Van Erps P; Schapmans S; Cortvriend J; D'Hont C; Denis LJ
Acta Urol Belg; 1995 Sep; 63(3):39-43. PubMed ID: 7484521
[TBL] [Abstract][Full Text] [Related]
2. Prospective multicenter ProLase II clinical trial of neodymium:yttrium-aluminum-garnet laser prostatectomy.
Kabalin JN; Gill HS; Leach GE; Bowers GW; Nill T; Konowalchuk TW
Urology; 1997 Jul; 50(1):63-5. PubMed ID: 9218020
[TBL] [Abstract][Full Text] [Related]
3. Laser prostatectomy performed with a right-angle firing neodymium:YAG laser fiber at 60 watts power setting.
Kabalin JN; Gill HS; Bite G
J Urol; 1995 May; 153(5):1502-5. PubMed ID: 7536256
[TBL] [Abstract][Full Text] [Related]
4. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
[TBL] [Abstract][Full Text] [Related]
6. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
7. Effects of photoselective vaporization of the prostate on urodynamics in patients with benign prostatic hyperplasia.
Seki N; Nomura H; Yamaguchi A; Naito S
J Urol; 2008 Sep; 180(3):1024-8; discussion 1028-9. PubMed ID: 18639299
[TBL] [Abstract][Full Text] [Related]
8. Visual laser ablation of the prostate (VLAP): an effective alternative treatment of benign prostatic hyperplasia.
Mattelaer P; Jung P; Wolff J; Jakse G
Acta Urol Belg; 1995 Sep; 63(3):45-9. PubMed ID: 7484522
[TBL] [Abstract][Full Text] [Related]
9. [The VLAP system (Visual Laser Ablation of the Prostate): comparative study of the contact versus non-contact techniques in a series of 100 cases].
Breteau D; Koutani A; Albert P; Morin N; Salvo A
Prog Urol; 1997 Apr; 7(2):235-9. PubMed ID: 9264765
[TBL] [Abstract][Full Text] [Related]
10. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia.
Narayan P; Tewari A; Aboseif S; Evans C
J Urol; 1995 Dec; 154(6):2083-8. PubMed ID: 7500464
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia.
Tubaro A; Carter S; Hind A; Vicentini C; Miano L
J Urol; 2001 Jul; 166(1):172-6. PubMed ID: 11435849
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
[TBL] [Abstract][Full Text] [Related]
13. Transurethral ultrasound-guided laser-induced prostatectomy. Objective and subjective assessment of its efficacy for treating benign prostatic hyperplasia.
Puppo P; Perachino M; Ricciotti G; Scannapieco G
Eur Urol; 1994; 25(3):220-5. PubMed ID: 7515349
[TBL] [Abstract][Full Text] [Related]
14. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
[TBL] [Abstract][Full Text] [Related]
15. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
Schatzl G; Madersbacher S; Lang T; Marberger M
J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
[TBL] [Abstract][Full Text] [Related]
16. Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases.
Seki N; Mochida O; Kinukawa N; Sagiyama K; Naito S
J Urol; 2003 Nov; 170(5):1847-50. PubMed ID: 14532790
[TBL] [Abstract][Full Text] [Related]
17. High power potassium-titanyl-phosphate laser vaporization prostatectomy.
Malek RS; Kuntzman RS; Barrett DM
J Urol; 2000 Jun; 163(6):1730-3. PubMed ID: 10799170
[TBL] [Abstract][Full Text] [Related]
18. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
[TBL] [Abstract][Full Text] [Related]
19. Laser prostatectomy: initial experience and urodynamic follow-up.
Cummings JM; Parra RO; Boullier JA
Urology; 1995 Mar; 45(3):414-8; discussion 418-20. PubMed ID: 7533453
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
